Cargando…
Dual Pharmacological Targeting of HDACs and PDE5 Inhibits Liver Disease Progression in a Mouse Model of Biliary Inflammation and Fibrosis
SIMPLE SUMMARY: Chronic liver injury and inflammation leads to excessive deposition of extracellular matrix, known as liver fibrosis, and the distortion of the hepatic parenchyma. Liver fibrosis may progress to cirrhosis, a condition in which hepatic function is impaired and most cases of liver tumo...
Autores principales: | Claveria-Cabello, Alex, Colyn, Leticia, Uriarte, Iker, Latasa, Maria Ujue, Arechederra, Maria, Herranz, Jose M., Alvarez, Laura, Urman, Jesus M., Martinez-Chantar, Maria L., Banales, Jesus M., Sangro, Bruno, Rombouts, Krista, Oyarzabal, Julen, Marin, Jose J. G., Berasain, Carmen, Avila, Matias A., Fernandez-Barrena, Maite G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7763137/ https://www.ncbi.nlm.nih.gov/pubmed/33322158 http://dx.doi.org/10.3390/cancers12123748 |
Ejemplares similares
-
Epigenetics in Liver Fibrosis: Could HDACs be a Therapeutic Target?
por: Claveria-Cabello, Alex, et al.
Publicado: (2020) -
Comprehensive analysis of epigenetic and epitranscriptomic genes’ expression in human NAFLD
por: Herranz, Jose M., et al.
Publicado: (2023) -
Splicing events in the control of genome integrity: role of SLU7 and truncated SRSF3 proteins
por: Jiménez, Maddalen, et al.
Publicado: (2019) -
The splicing regulator SLU7 is required to preserve DNMT1 protein stability and DNA methylation
por: Recalde, Miriam, et al.
Publicado: (2021) -
New molecular mechanisms in cholangiocarcinoma: signals triggering interleukin-6 production in tumor cells and KRAS co-opted epigenetic mediators driving metabolic reprogramming
por: Colyn, Leticia, et al.
Publicado: (2022)